Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04081753 · ClinicalTrials.gov registry record · NA
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy
A NA study, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04081753 is a NA study that has completed, run by Augusta University. The registered enrollment target is 12 participants.
The verdict
NCT04081753, a NA study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Febrile neutropenic patients are at high risk for developing sepsis and other infections which often necessitates acute admission to the Intensive Care Unit (ICU) and are associated with high mortality. Neutropenic fever is a medical emergency and early detection of fever allows for prompt infectious work up. In this study, the investigators will collect pilot data from outpatients utilizing a remote outpatient continuous temperature monitoring device to compare the incidence of ICU admission and severe sepsis to historical data for prior patients who did not receive at home monitoring device.
Interventions
- DEVICE Remote monitoring of temperature
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04081753
The ClinicalTrials.gov registry entry for NCT04081753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remote monitoring of temperature is the first listed.
NCT04081753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04081753 about?
NCT04081753 is a clinical study titled "Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy". Febrile neutropenic patients are at high risk for developing sepsis and other infections which often necessitates acute admission to the Intensive Care Unit (ICU) and are associated with high mortality. Neutropenic fever is a medical emergency and early detection of fever allows for prompt infectiou...
What is the current status of trial NCT04081753?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-12-16. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT04081753?
The interventions under investigation include: Remote monitoring of temperature (DEVICE).
Who is sponsoring clinical trial NCT04081753?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.